Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Controversy on the management of patients carrying RET p.V804M mutation.

Endocrine - 1 Feb 2022

Alzahrani Ali S, Alswailem Meshael, Alghamdi Balgees, Rafiullah Rafiullah, Aldawish Mohammed, Al-Hindi Hindi

Abstract excerpt

CONTEXT: RET p.V804M is classified as a moderate risk mutation for familial medullary thyroid cancer (FMTC). There is a significant controversy on the management of patients carrying this mutation. We describe a family incidentally discovered to have this mutation and review the literature on RET p.V804M mutation. RESULTS: The proband was born to first-degree relative parents. He was noticed to have hypertrophy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Medullary
Share to Germ-Line Mutation
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pedigree

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 34637071
DOI: 10.1007/s12020-021-02895-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Controversy on the management of patients carrying RET p.V804M mutation.PMID 34637071Read ↗

Controversy on the Management of Patients Carrying RET p.V804M MutationSemantic proximity Read ↗

Hereditary medullary thyroid carcinoma: the management dilemma.Semantic proximity Read ↗

A primer on the genetics of medullary thyroid cancer.Semantic proximity Read ↗

Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience.Semantic proximity Read ↗

Population Prevalence of the Major Thyroid Cancer-Associated Syndromes.Semantic proximity Read ↗

Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?Semantic proximity Read ↗

The clinical consequences of diagnostic delay in sporadic pediatric MEN2B: a case series of 6 children.Semantic proximity Read ↗

Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.Semantic proximity Read ↗

Management of hereditary medullary thyroid carcinoma.Semantic proximity Read ↗

The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.Semantic proximity Read ↗

Approach to the Patient: Hereditary Medullary Thyroid CarcinomaSemantic proximity Read ↗

Mutation Spectrum and Associated Risks of Medullary Thyroid Cancer and All-Cause Mortality in Incidentally Identified MEN2A-Causing<i>RET</i>VariantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.